Clerkenwell Health closed its initial round of funding to launch a clinical research organisation with key hires and a partnership with Manchester University. Funding came from a mix of British angel investors and psychedelic focussed VCs including Vine Ventures.
Category Press Release
Published in Clerkenwell Health
Companies Featured
Vine VenturesVine is a prolific venture capital fund operating in the world of psychedelics with the philosophy of reciprocity at its core.
Clerkenwell Health
Clerkenwell is a clinical research organisation (CRO) in the UK that supports drug developers as they attempt to commercialise psychedelic therapies. Clerkenwell offers support from preclinical studies up to Phase III of the drug development process.